WAQAR SIDDIQUI: Open Payments
NPI 1699840314 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 21 payments from 8 companies in 2025. Trend: 2023 $2,352 · 2024 $1,691 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $134 |
| Alkermes, Inc. | 7 | $120 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: AUSTEDO XR, ARISTADA, LYBALVI, ABILIFY MAINTENA, REXULTI, COBENFY, INVEGA SUSTENNA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
